We are live on ! Find out more
ADIL

Adial Pharmaceuticals
ADIL

10 hedge funds and large institutions have $817K invested in Adial Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 8 → 10 (+2)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

45% less capital invested

Capital invested by funds: $1.48M → $817K (-$664K)

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$23.5K
2
Victory Capital Management
Victory Capital Management
Texas
+$5.34K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$368K – – –
BlackRock
2
BlackRock
New York
$267K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$101K – – –
Brown Advisory
4
Brown Advisory
Maryland
$34K – – –
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$18K +$23.5K +22 New
Commonwealth Equity Services
6
Commonwealth Equity Services
Massachusetts
$13K – – –
Osaic Holdings
7
Osaic Holdings
Arizona
$10K +$13.9K +13 New
Victory Capital Management
8
Victory Capital Management
Texas
$4K +$5.34K +5 New
Morgan Stanley
9
Morgan Stanley
New York
$1K – – –
Wells Fargo
10
Wells Fargo
California
$1K – – –

ADIL Hedge Fund Activity: Q1 2020 in Review

10 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q1 2020, worth a combined $817K — down 45% from $1.48M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ADIL positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $23.5K.

  • 10 institutional investors held Adial Pharmaceuticals (ADIL) as of Q1 2020, up from 8 in Q4 2019.
  • Funds reported $817K of Adial Pharmaceuticals stock for Q1 2020, down 45% quarter-over-quarter.
  • 3 funds opened new Adial Pharmaceuticals positions in Q1 2020 and 0 closed out, a net change of +3 holders.
  • The largest Adial Pharmaceuticals buyer in Q1 2020 was Susquehanna International Group, an estimated $23.5K added.

Based on aggregated 13F filings for Q1 2020.